north40000
6 minutes ago
“Present generic” for TEVA—looks like TEVA has reneged on its initial settlement years ago, and now has joined the Hikma, Dr. Reddy, and the rest of the Generic cartel seeking a share of Amarin’s CVD market space. None of the above generics should be in the high triglyceride market space either, in